| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 1853 | 2017 |
| The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease P Barone, A Antonini, C Colosimo, R Marconi, L Morgante, TP Avarello, ... Movement disorders: official journal of the Movement Disorder Society 24 (11 …, 2009 | 1822 | 2009 |
| Valvular heart disease and the use of dopamine agonists for Parkinson's disease R Zanettini, A Antonini, G Gatto, R Gentile, S Tesei, G Pezzoli New England Journal of Medicine 356 (1), 39-46, 2007 | 1058 | 2007 |
| Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study CW Olanow, K Kieburtz, P Odin, AJ Espay, DG Standaert, HH Fernandez, ... The Lancet Neurology 13 (2), 141-149, 2014 | 740 | 2014 |
| Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ... Nature genetics 43 (7), 699-705, 2011 | 645 | 2011 |
| EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease A Berardelli, GK Wenning, A Antonini, D Berg, BR Bloem, V Bonifati, ... European journal of neurology 20 (1), 16-34, 2013 | 641 | 2013 |
| Integrated care prevents hospitalisations for exacerbations in COPD patients A Casas, T Troosters, J Garcia-Aymerich, J Roca, C Hernández, A Alonso, ... European Respiratory Journal 28 (1), 123-130, 2006 | 577 | 2006 |
| Parkinson’s disease: the non-motor issues KR Chaudhuri, P Odin, A Antonini, P Martinez-Martin Parkinsonism & related disorders 17 (10), 717-723, 2011 | 526 | 2011 |
| miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition A Magenta, C Cencioni, P Fasanaro, G Zaccagnini, S Greco, ... Cell Death & Differentiation 18 (10), 1628-1639, 2011 | 479 | 2011 |
| Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F] fluorodeoxyglucose (FDG) FX Vollenweider, KL Leenders, C Scharfetter, A Antonini, P Maguire, ... European neuropsychopharmacology 7 (1), 9-24, 1997 | 449 | 1997 |
| Patterns of regional brain activation associated with different forms of motor learning MF Ghilardi, C Ghez, V Dhawan, J Moeller, M Mentis, T Nakamura, ... Brain research 871 (1), 127-145, 2000 | 440 | 2000 |
| Levodopa in the treatment of Parkinson’s disease: an old drug still going strong W Poewe, A Antonini, JCM Zijlmans, PR Burkhard, F Vingerhoets Clinical interventions in aging, 229-238, 2010 | 428 | 2010 |
| Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes V Bonifati, CF Rohe, GJ Breedveld, E Fabrizio, M De Mari, C Tassorelli, ... Neurology 65 (1), 87-95, 2005 | 420 | 2005 |
| Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease A Antonini, KL Leenders, R Spiegel, D Meier, P Vontobel, ... Brain 119 (6), 2085-2095, 1996 | 393 | 1996 |
| Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease: A national multicenter parallel–group randomized study P Barone, L Scarzella, R Marconi, A Antonini, L Morgante, F Bracco, ... Journal of neurology 253, 601-607, 2006 | 373 | 2006 |
| Functional brain networks in DYT1 dystonia D Eidelberg, JR Moeller, A Antonini, K Kazumata, T Nakamura, V Dhawan, ... Annals of neurology 44 (3), 303-312, 1998 | 365 | 1998 |
| Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life H Honig, A Antonini, P Martinez‐Martin, I Forgacs, GC Faye, T Fox, K Fox, ... Movement disorders: official journal of the Movement Disorder Society 24 (10 …, 2009 | 327 | 2009 |
| Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease P Martinez-Martin, C Falup Pecurariu, P Odin, JJ van Hilten, A Antonini, ... Journal of neurology 259, 1639-1647, 2012 | 326 | 2012 |
| Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease A Antonini, W Poewe The Lancet Neurology 6 (9), 826-829, 2007 | 313 | 2007 |
| Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study G Defazio, A Berardelli, G Fabbrini, D Martino, E Fincati, A Fiaschi, ... Archives of neurology 65 (9), 1191-1194, 2008 | 310 | 2008 |
K Ray ChaudhuriProfessor of Neurology, King's College Hospiatl and King's College, LondonEmail verificata su nhs.net
